6.16000 CAD
0.16
2.67%
Last update Dec 18, 3:59 PM EST
Market closed
Day range
6
6.53000
Previous close
6
Open
6.050000
Access this stock data via API
Subscribe
Nervgen Pharma Corp.
6.16
0.16
2.67%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 15.7M 8.0M 16.6M 6.9M
Selling general and admin 9.2M 9.6M 6.3M 5.9M
Other operating expenses
Operating income -24.9M -17.8M -23.0M -12.8M
Non operating interest income
Income 812.6K 550.1K 201.4K 29.4K
Expense 0 514.6K 0
Other income expense 113.5K -5.2M 2.6M 55.2K
Pretax income -24.0M -22.4M -20.7M -12.7M
Tax provision
Net income -24.0M -22.4M -20.7M -12.7M
Basic EPS -0.4 -0.4 -0.4 -0.3
Diluted EPS -0.4 -0.4 -0.4 -0.3
Basic average shares 67.3M 59.3M 52.6M 39.3M
Diluted average shares 67.3M 59.3M 52.6M 39.3M
EBITDA -25.0M -17.1M -22.7M -12.7M
Net income from continuing op. -24.0M -22.4M -20.7M -12.7M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 14 hours 37 minutes

17:22
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 17:00
All times are displayed in the America/Toronto timezone (EST, UTC-05:00).